TY - JOUR
T1 - Trends in sinusitis research
T2 - a systematic review of extramural funding
AU - Levy, Joshua M.
AU - Smith, Stephanie Shintani
AU - Varshney, Rickul
AU - Chang, Eugene H.
AU - Ramakrishnan, Vijay R.
AU - Ting, Jonathan Y.
AU - Bleier, Benjamin S.
N1 - Funding Information:
Descriptive project terms for currently active (FY 2017) studies are arranged by prevalence and relationship and are presented in Figure 2. Among active studies, 9 investigators maintain membership in the ARS, and serve as principal investigator or project leader in 12 of these studies. ARS investigators received the greatest number of awards from the National Institute on Deafness and Other Communication Disorders (NIDCD; n = 8, 66.7%), while only receiving 2.2% of awarded funding from the National Institutes of Allergy and Infectious Disease (NIAID; $607,500 / $26,873,022), the largest source of sinusitis-related funding. See Table S1 in the Supplementary Material (available online) for a summary of sinusitis-related awards by administering institute. R-series, independent awards are most prevalent among active sinusitis studies (R01 or R21, n = 56), followed by K-series career development awards (K23, n = 10). See Table S2 in Supplementary Material online for a summary of sinusitis awards by NIH activity code. A total of 3 NIH career development awards are currently awarded to ARS investigators.
Funding Information:
The acquisition of extramural funding is a competitive process, with average grant acceptance rates of 16% to 27% among national funding agencies.8 A thoughtful approach is therefore necessary to identify effective strategies for obtaining funding, with an understanding of institutional priorities and trends in extramural support. Recent work has demonstrated significant advancement in the quality and quantity of rhinology research over the past 3 decades, with a 637% increase in number of rhinology publications, as well as an increased prevalence of prospective study designs and better overall study quality.9 Despite these advancements, however, a large disparity remains when comparing grant funding for CRS versus other chronic conditions with similar prevalence and associated healthcare costs. Hopkins and Rudmik8 recently reviewed grant funding from Canada, the United Kingdom, and the United States and found significantly fewer awards and funding in support of CRS research when compared with asthma, diabetes, and dementia. To adapt, CRS researchers have become highly efficient, using 8-to 12-fold less funding per publication.8 The findings presented in the current study
Funding Information:
FIGURE 2. Multiple-level pie-chart visualization of sinusitis-related projects currently supported by the NIH. Clustered representation of project terms by overall frequency and relationship. NIH = National Institutes of Health.
Publisher Copyright:
© 2017 ARS-AAOA, LLC
PY - 2017/11
Y1 - 2017/11
N2 - Background: Innovation represents a core value of the American Rhinologic Society (ARS), with multiple efforts to promote research in the advancement rhinologic care. We therefore sought to identify trends in extramural sinusitis funding and underutilized sources of support to facilitate future efforts. Methods: A systematic review of the National Institutes of Health (NIH) Research Portfolio Online Tools (RePORTER) database (fiscal year 1993 to 2017) was completed with the search strategy: (“chronic sinusitis” OR rhinosinusitis). All identified studies were accepted for review, with comparison to ARS membership rolls to identify studies supported by ARS investigators. Foundation awards were surveyed to identify and characterize additional sources of support. Results: The systematic review identified 958 projects receiving NIH funding, of which 120 remain active. The percentage of sinusitis-related awards and total funding relative to all NIH awards increased over the past 10 years (2006 to 2016) from 0.06% (8 / 9128) and 0.09% ($2,151,152 / $3,358,338,602) to 0.87% (86 / 9540) and 0.90% ($37,201,095 / $4,300,145,614). Among active studies, 9 investigators maintain membership in the ARS and serve as principal investigator or project leader in 12 (10%) studies. ARS investigators received the greatest number of awards from the National Institute on Deafness and Other Communication Disrders (n = 8,66.7%), while only receiving 2.2% of awarded funding from the National Institute of Allergy and Infectious Diseases ($607,500/$26,873,022), the largest source of awards for sinusitis research. Conclusion: Support for sinusitis research is significantly growing, with the largest source of active funding not being fully utilized by members of the ARS. Further efforts to promote funding priorities among extramural sources is necessary to facilitate increased funding for ARS member initiatives.
AB - Background: Innovation represents a core value of the American Rhinologic Society (ARS), with multiple efforts to promote research in the advancement rhinologic care. We therefore sought to identify trends in extramural sinusitis funding and underutilized sources of support to facilitate future efforts. Methods: A systematic review of the National Institutes of Health (NIH) Research Portfolio Online Tools (RePORTER) database (fiscal year 1993 to 2017) was completed with the search strategy: (“chronic sinusitis” OR rhinosinusitis). All identified studies were accepted for review, with comparison to ARS membership rolls to identify studies supported by ARS investigators. Foundation awards were surveyed to identify and characterize additional sources of support. Results: The systematic review identified 958 projects receiving NIH funding, of which 120 remain active. The percentage of sinusitis-related awards and total funding relative to all NIH awards increased over the past 10 years (2006 to 2016) from 0.06% (8 / 9128) and 0.09% ($2,151,152 / $3,358,338,602) to 0.87% (86 / 9540) and 0.90% ($37,201,095 / $4,300,145,614). Among active studies, 9 investigators maintain membership in the ARS and serve as principal investigator or project leader in 12 (10%) studies. ARS investigators received the greatest number of awards from the National Institute on Deafness and Other Communication Disrders (n = 8,66.7%), while only receiving 2.2% of awarded funding from the National Institute of Allergy and Infectious Diseases ($607,500/$26,873,022), the largest source of awards for sinusitis research. Conclusion: Support for sinusitis research is significantly growing, with the largest source of active funding not being fully utilized by members of the ARS. Further efforts to promote funding priorities among extramural sources is necessary to facilitate increased funding for ARS member initiatives.
KW - chronic disease
KW - research
KW - sinusitis
UR - http://www.scopus.com/inward/record.url?scp=85032680077&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85032680077&partnerID=8YFLogxK
U2 - 10.1002/alr.22015
DO - 10.1002/alr.22015
M3 - Article
C2 - 28985031
AN - SCOPUS:85032680077
SN - 2042-6976
VL - 7
SP - 1104
EP - 1107
JO - International Forum of Allergy and Rhinology
JF - International Forum of Allergy and Rhinology
IS - 11
ER -